Trillium Therapeutics Inc. (TRIL)

8.26
0.87 11.77
NASDAQ
Prev Close 7.39
Open 7.39
Day Low/High 7.25 / 8.30
52 Wk Low/High 0.24 / 9.66
Volume 1.85M
Exchange NASDAQ
Shares Outstanding 83.19B
Market Cap 632.22M
P/E Ratio 4.72
Div & Yield N.A. (N.A)

Latest News

There Are 2 Types of Trading Markets: This Is the Good One

There Are 2 Types of Trading Markets: This Is the Good One

Here's what I'm trading and what's on my radar today.

The Market Can Remain Irrational Longer Than You Can Remain Solvent

The Market Can Remain Irrational Longer Than You Can Remain Solvent

If the market can't sell off on this news then what reason does it have to dip?

I'm Focused More on Stock Picks Than Indices

I'm Focused More on Stock Picks Than Indices

You need not be a rip-snorting bull to still find some stocks that look pretty good on a technical basis.

Here's How I'm Positioned and What I'm Holding

Here's How I'm Positioned and What I'm Holding

I see no reason to put much money into longer-term positions right now, but here are some of my biggest positions.

Overall Market Conditions Look Poor But There Are Hot Pockets of Trading Action

Overall Market Conditions Look Poor But There Are Hot Pockets of Trading Action

Stocks are not moving in highly correlated action, which favors stock-pickers and technical buyers.

There's No Reason to Believe That the Indices Are Going to Hold at This Point

There's No Reason to Believe That the Indices Are Going to Hold at This Point

It's looking like the trading range I've been talking about may be developing now.

Small-Cap Stocks Keep Traders Bullish: 2 Sectors to Watch

Small-Cap Stocks Keep Traders Bullish: 2 Sectors to Watch

There is nothing in small-caps to suggest that they are as frothy as the big-caps.

Tuesday Was Telling About Today's Trading

Tuesday Was Telling About Today's Trading

One group that is starting to look interesting is Master Limited Partnerships.

Take a Chill Pill: If Clinton Wins, Drug-Price Controls Aren't Guaranteed

Take a Chill Pill: If Clinton Wins, Drug-Price Controls Aren't Guaranteed

Such unwarranted fears have depressed the sector, which could bounce back after Nov. 8.

Shark Bites: Market Responds With 'Deutsche Who?'

Shark Bites: Market Responds With 'Deutsche Who?'

Report of settlement turns the market.

Both Bulls and Bears Are Looking for a Breakout

Both Bulls and Bears Are Looking for a Breakout

The end of the quarter is approaching and might impact action in individual names.

I Am One of the Underinvested Bulls Right Now

I Am One of the Underinvested Bulls Right Now

It's challenging to put cash to work but I'll keep digging.

These Biotech Names Are on My Radar

These Biotech Names Are on My Radar

But I'm expecting that things will slow into the Fed news.

A Down Day, But No Cause for Alarm

Thin volume likely ahead of holiday weekend.

This Isn't What This Market Needs

A flood of supply in a nervous market isn't a good idea.